Palliative Care Decreases Hospital Readmissions in Ovarian Cancer


Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Palliative care, which focuses on easing the symptoms associated with cancer and its treatments, decreased the rate at which patients with ovarian cancer were readmitted to the hospital in a 90-day timeframe, according to recent research presented at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer.

Study author Dr. Alex Francoeur, resident at UCLA Health, explained for patients who had a palliative care consultation, the 90-day hospital readmission rate was 27% compared with 44% for those who did not have a palliative care consultation. Additionally, over the course of a full calendar year, hospital readmission rates dropped by 50% for patients with ovarian cancer who had palliative care. This also led to cost savings for both the patients and health care systems.

“Many organizations recommend (palliative care) implementation at the time of diagnosis,” Francoeur said in an interview with CURE®’s sister publication, Cancer Network®. “Unfortunately, the data and research still shows that patients are really being referred to (palliative care) late, more often at the end of life. So I think we have a lot to do in increasing earlier referrals for our patients.”

Francoeur explained that people often have misconceptions about palliative care, mainly that it is reserved for people when they are at the end of their life. However, that’s not the case, and the American Cancer Society noted that palliative care can be given at any point of the treatment continuum: at diagnosis, throughout treatment and even within the survivorship phase.

READ MORE: What Is Palliative Care? Top 4 Questions Answered

“Patients can always advocate for themselves,” Francoeur said. “Asking if there is a palliative care team in the hospital would definitely be a warranted request for patients with advanced cancer, and most large institutions do have palliative care services. It would be great to ask your doctor how to get connected with those.”


Palliative care is the concept of treating symptoms associated with cancer and versus cancer treatment, which is trying to treat the cancer itself. And so these are usually doctors who are subspecialty trained in palliative medicine and so they're able to help patients focus on symptoms they may be experiencing from cancer or from the treatment for their cancer, such as pain, nausea, vomiting, neuropathy, numbness or weakness. And so these are doctors that kind of help alleviate all of those symptoms that can make cancer treatment challenging for patients.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Related Content